SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 83 filers reported holding SEELOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,241,003 | -79.9% | 6,744,585 | +30.5% | 0.07% | -85.2% |
Q2 2023 | $6,175,784 | +76.3% | 5,168,020 | +2.0% | 0.48% | +46.0% |
Q1 2023 | $3,503,015 | +5.1% | 5,068,020 | +3.2% | 0.33% | +11.2% |
Q4 2022 | $3,333,024 | -34.1% | 4,908,725 | 0.0% | 0.30% | -55.4% |
Q3 2022 | $5,056,000 | +51.4% | 4,908,725 | 0.0% | 0.66% | +71.5% |
Q2 2022 | $3,340,000 | -19.2% | 4,908,725 | -0.5% | 0.39% | +30.0% |
Q1 2022 | $4,133,000 | +3.5% | 4,933,024 | +101.4% | 0.30% | -8.3% |
Q4 2021 | $3,992,000 | -10.9% | 2,449,267 | +31.7% | 0.32% | -15.8% |
Q3 2021 | $4,481,000 | -2.6% | 1,859,635 | +6.7% | 0.38% | -5.6% |
Q2 2021 | $4,601,000 | -24.7% | 1,742,776 | +42.2% | 0.41% | -37.4% |
Q1 2021 | $6,114,000 | – | 1,225,244 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |